Daiichi Sankyo Co., Ltd. (DSKYF)
14.86
-1.34
(-8.27%)
USD |
OTCM |
Jun 09, 16:00
Daiichi Sankyo EPS Diluted (Quarterly) : 0.1472 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1472 |
| December 31, 2025 | 0.3035 |
| September 30, 2025 | 0.166 |
| June 30, 2025 | 0.3183 |
| March 31, 2025 | 0.3037 |
| December 31, 2024 | 0.2152 |
| September 30, 2024 | 0.2159 |
| June 30, 2024 | 0.286 |
| March 31, 2024 | 0.1305 |
| December 31, 2023 | 0.2345 |
| September 30, 2023 | 0.1442 |
| June 30, 2023 | 0.2161 |
| March 31, 2023 | 0.0885 |
| December 31, 2022 | 0.1046 |
| September 30, 2022 | 0.1487 |
| June 30, 2022 | 0.0757 |
| March 31, 2022 | -0.1227 |
| December 31, 2021 | 0.146 |
| September 30, 2021 | 0.129 |
| June 30, 2021 | 0.1678 |
| March 31, 2021 | 0.0007 |
| December 31, 2020 | 0.1188 |
| September 30, 2020 | 0.0958 |
| June 30, 2020 | 0.1521 |
| March 31, 2020 | -0.0246 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.3299 |
| September 30, 2019 | 0.1008 |
| June 30, 2019 | 0.2025 |
| March 31, 2019 | 0.0681 |
| December 31, 2018 | 0.1584 |
| September 30, 2018 | 0.0924 |
| June 30, 2018 | 0.1126 |
| March 31, 2018 | -0.0581 |
| December 31, 2017 | 0.1707 |
| September 30, 2017 | 0.0232 |
| June 30, 2017 | 0.1315 |
| March 31, 2017 | -0.1536 |
| December 31, 2016 | 0.1791 |
| September 30, 2016 | 0.0885 |
| June 30, 2016 | 0.138 |
| March 31, 2016 | -0.1205 |
| December 31, 2015 | 0.1604 |
| September 30, 2015 | 0.1414 |
| June 30, 2015 | 0.1363 |
| December 31, 2014 | 0.2143 |
| September 30, 2014 | 0.1379 |
| June 30, 2014 | 0.0925 |
| December 31, 2013 | 0.2075 |
| September 30, 2013 | 0.0947 |
| June 30, 2013 | 0.0528 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Astellas Pharma, Inc. | 0.1543 |
| Takeda Pharmaceutical Co., Ltd. | -0.0496 |
| Eisai Co., Ltd. | -0.0184 |
| Chugai Pharmaceutical Co., Ltd. | 0.2235 |
| Santen Pharmaceutical Co., Ltd. | 0.3043 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 270.42M |
| Revenue (Quarterly) | 3.758B |
| Total Expenses (Quarterly) | 3.487B |
| Enterprise Value | 26.10B |
| Gross Profit Margin (Quarterly) | 48.70% |
| Profit Margin (Quarterly) | 7.20% |
| Earnings Yield | 6.29% |
| Operating Earnings Yield | 5.07% |